Biobot Analytics Inc.
Cambridge, MA
- UEI
- HLKDDRDLJAP9
- CAGE
- 885N6
- Primary NAICS
- 541380 Testing Laboratories and Services
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 541380 Testing Laboratories and Services Primary
- 518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration date
- Physical address
- 501 Massachusetts Ave, Cambridge, MA 02139, USA
- Website
- biobot.io
- Founded
- 2017
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Real time drug consumption data | Office of Administration | $775,338 | |
| Collecting and disseminating real-time drug consumption data through wastewater testing | Office of Administration | $615,700 | |
| FY23. Wastewater-based monitoring of illicit drugs POP 9/1/23 - 8/31/24. | National Institute on Drug Abuse | $799,971 | |
| Covid-19 wastewater sample analysis | Medical Command | $3,120 | |
| Wastewater testing for covid-19 | CDC Pittsburgh | $31,077,006 |
About Biobot Analytics Inc.
Biobot Analytics Inc. is a Cambridge, Massachusetts-based corporate entity specializing in wastewater-based epidemiology and data analysis, focusing on monitoring public health trends through advanced wastewater testing techniques. Registered in SAM.gov since January 2019, the company is self-certified as a small disadvantaged business and a for-profit organization. As a provider of specialized scientific services to federal agencies, Biobot Analytics has developed expertise in collecting, analyzing, and disseminating real-time data about drug consumption, infectious disease prevalence, and viral transmission through comprehensive wastewater surveillance methodologies.
The company has secured multiple significant federal contract awards from agencies including the Department of Health and Human Services, National Institutes of Health, Centers for Disease Control and Prevention, and the Department of Defense. These contracts, ranging from $3,120 to $31 million, have predominantly focused on COVID-19 and illicit drug monitoring through wastewater testing. Most contracts were either not set aside or designated as total small business set-asides, with performance periods typically spanning several months to a year. Specific contract objectives have included quantitative testing of wastewater samples for SARS-CoV-2, sequencing virus variants, monitoring illicit drug consumption, and providing rapid data analysis to support public health tracking and intervention strategies.
Regarding grant awards, Biobot Analytics has engaged in at least one notable sub grant award with the Maine Department of Health and Human Services, scheduled for November 2024. This sub grant focuses on conducting SARS-CoV-2 wastewater surveillance across multiple wastewater utilities in Maine. While the provided documentation shows limited grant award information, the sub grant demonstrates the company's continued involvement in state-level public health monitoring efforts, extending its federal contract work into collaborative state-based research and surveillance initiatives.
SBA capabilities narrative
We offer wastewater epidemiology services that include the design of a sampling program, laboratory testing of wastewater for Covid19, opioids, and other public health targets, data analysis and visualization into PDF reports and software dashboards/APIs.
Quick answers
What is Biobot Analytics Inc.'s UEI?
Biobot Analytics Inc.'s Unique Entity ID (UEI) in SAM.gov is HLKDDRDLJAP9.
What is Biobot Analytics Inc.'s CAGE code?
Biobot Analytics Inc.'s CAGE code is 885N6.
What is Biobot Analytics Inc.'s primary NAICS code?
Biobot Analytics Inc.'s primary NAICS code is 541380 (Testing Laboratories and Services).
Where is Biobot Analytics Inc. located?
Biobot Analytics Inc.'s physical address in SAM.gov is 501 Massachusetts Ave, Cambridge, MA 02139, USA.
Is Biobot Analytics Inc. registered in SAM.gov?
Yes. Biobot Analytics Inc.'s SAM.gov registration is active through February 19, 2027.
What is Biobot Analytics Inc.'s most recent federal award?
Biobot Analytics Inc.'s most recent federal contract award is Real time drug consumption data (11316026P0001OND), from Office of Administration, on September 28, 2026.
On GovTribe
See Biobot Analytics Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors